We would love to hear your thoughts about our site and services, please take our survey here.
"It has been selected for two sessions at the ATS 2022 International Conference: The clinical trials symposium on May 16 and a thematic poster session entitled Expanding Our Insight Into COVID-19 a day later."
https://www.proactiveinvestors.co.uk/companies/news/978811/synairgen-to-present-data-from-phase-iii-covid-trial-at-leading-industry-conference-978811.html
.. just an interesting thought for the new post 21/2 era, where some (including myself) are just a little more wary of "quotes" that don't necessarily come with a definitive link. Some leeway maybe due to those with understandable caution going forward. I was certainly guilty of reading in or accepting any hint of positivity as a given 'truth'. As a LTH with sizeable retirement stake in this, with no funds to reduce my average, and no good at trading, I am certainly more cautiously optimistic going forward.
I think we need a direct link to this if it is a new update.
NIH ... Last update Feb 2, 2022 ... ?
https://clinicaltrials.gov/ct2/show/NCT04518410?term=ACTIV-2&draw=2
https://www.proactiveinvestors.co.uk/companies/news/975682/synairgen-updates-on-sng001-975682.html
... mood on here seems generally (and thankfully) more positive imho. We all get the frustration, but platitudes from SNG do nothing - no matter how much we love someone falling on their sword. Most of us, I'm sure, believe that RM & team are working flat out rather that wasting time agonising over an apology to investors, and with regard to all the interesting horizon views on here, I'm equally sure the team have already board-blasted these and more.
P3 Deep Dive, Peer Review, A2P2 results/analysis, A2P3 commencement (and comparator update), Platform Trial confirmation, and possibly more TR1's are the proposed tangibles ... but I suspect much more in terms of engagement with their recently expanded industry network of stakeholders, supporters, regulators, etc - particularly state-side. The one thing about an unexpected blow like this for SNG, is them being left with the strongest-possible incentive to, not only ingather the escaping 'ducks' but to find a few more and this time cement them securely them in a more impressive row than before.
We are still in the 'rabbit vs headlights' phase but a few on here have started to take a few steps back to add pre-21 Feb into their analysis of this very question. In short, take a breath and think back to 20 July 2020 - 20 Feb 2022 and what has developed. My suggestion is that P3 - whilst eagerly awaited and all hopes were being pinned on that turning point - has to be reviewed alongside what we already know from those previous 20 months. For me (not an expert in anything here) those 20 months (without anything yet from SNG to say otherwise) more than outweigh the potentially skewed results P3. Just a overall few rather than taking P3 results in isolation, never mind the fact that we have not yet finished this journey.
... it was said many times by most of us before Miserable Monday, but it's what I return to every morning at this time, namely that, in terms of why I invested, nothing has changed in terms of the product, the science, the 15+ years of research by world-class scientists, the P2 findings, the move up to A2P3 (that others were unable to achieve), and the mountain of recent new research material hailing the benefits of INF. We were moving through the not inconsiderable stages towards best in class.
Whilst P3 did not mirror its predecessor, we effectively know (yet to be formally confirmed) the reason why. It's annoying, but not some unknown and not a failing, per se, of the actual product ,that remains unique in the market and fully patented. For me, none of these tangibles have changed. I can't believe the ingenuity that brought SNG001 to where we are is wallowing in a smoke filled room full of empty beer cans. We are in a holding pattern after what can only be described as (an almost inevitable) hurdle on such a long and difficult road to commercialisation of a product already proven to work. Time is our enemy ... and dare I say ... a loss of belief ... which I hope had not affected/infected the Co. They will be working all out, and I've doubt earning their salaries, right now.
Within just under 2 years we have waited on the months, that turned to weeks, and latterly (for a short time) days. This heightened pace of expectation is what exacerbates the hurdle we have faced. There were delays before, this is another. I question myself daily as to why I'm not a total wreck and if I'm just in denial (others have said much the same, and it's helped reading my thoughts from keyboards of others), but I go back to the facts above and try hard to remove the emotion.
The Co. and the team got us to 20 Feb 2022, they deserve a week or so at the very least. It's been 15+ years for them. GLA.
... to be giving anyone any advice of what to do, not to do, or what will / will not happen with A2P3. We all need to let it sink in and stay calm. Some will be in a bad place and just need to know they are not alone .. so spare a thought to your posts on here
Most will be on here for comfort or to share our collective disappointment. I told the wife right away, glad I did, that was my biggest worry. Ironically, his is where a BB can do some good to help us help each other by just being here and sharing without sending hares racing in every direction. GLA, and keep your chin up.